Co-Authors
This is a "connection" page, showing publications co-authored by Kavita Babu and Stephanie Carreiro.
Connection Strength
1.336
-
Rigatti M, Chapman B, Chai PR, Smelson D, Babu K, Carreiro S. Digital Biomarker Applications Across the Spectrum of Opioid Use Disorder. Cogent Ment Health. 2023; 2(1).
Score: 0.224
-
Pepin MD, Joseph JK, Chapman BP, McAuliffe C, O'Donnell LK, Marano RL, Carreiro SP, Garcia EJ, Silk H, Babu KM. A mobile addiction service for community-based overdose prevention. Front Public Health. 2023; 11:1154813.
Score: 0.224
-
Chapman BP, Lucey E, Boyer EW, Babu KM, Smelson D, Carreiro S. Perceptions on wearable sensor-based interventions for monitoring of opioid therapy: A qualitative study. Front Digit Health. 2022; 4:969642.
Score: 0.213
-
Lai JT, Goldfine CE, Chapman BP, Taylor MM, Rosen RK, Carreiro SP, Babu KM. Nobody Wants to Be Narcan'd: A Pilot Qualitative Analysis of Drug Users' Perspectives on Naloxone. West J Emerg Med. 2021 Feb 08; 22(2):339-345.
Score: 0.189
-
Lai JT, Chapman BP, Carreiro SP, Costigan AD, Rodriguez-Perez KM, Gonzalez G, Babu KM. A Pilot Study of a Telemedicine-based Substance Use Disorder Evaluation to Enhance Access to Treatment Following Near-Fatal Opioid Overdose. Proc Annu Hawaii Int Conf Syst Sci. 2020; 2020:3488-3496.
Score: 0.175
-
Bradley ES, Liss D, Carreiro SP, Brush DE, Babu K. Potential uses of naltrexone in emergency department patients with opioid use disorder. Clin Toxicol (Phila). 2019 Sep; 57(9):753-759.
Score: 0.165
-
Rosenbaum CD, Carreiro SP, Babu KM. Here today, gone tomorrow?and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines. J Med Toxicol. 2012 Mar; 8(1):15-32.
Score: 0.102
-
Lai JT, Chapman BP, Carreiro SP, Babu KM, Boyer EW, Chai PR. Understanding Naloxone Uptake from an Emergency Department Distribution Program Using a Low-Energy Bluetooth Real-time Location System. J Med Toxicol. 2020 10; 16(4):405-415.
Score: 0.045